Keith C Bible

5PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 07, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer.

Lori J Wirth, Marcia S Brose, Eric J Sherman

|Mar 22, 2021
Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.

Alan L Ho, Irene Brana, Robert Haddad

|Jul 16, 2020
Salvage Therapy With Multikinase Inhibitors and Immunotherapy in Advanced Adrenal Cortical Carcinoma.

Kevin C Miller, Ashish V Chintakuntlawar, Crystal Hilger

|Nov 03, 2017
Effect of thyroid hormone suppression on control of advanced well-differentiated thyroid cancer.

Nicole M Iñiguez-Ariza, Marius N Stan, Keith C Bible

Pageof 1